# clm_8C3635AEC49A

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 5,307,100,000 United States dollar  
valid_from: 2018-12-31  
valid_to: 2019-12-31  
published: 2019-02-19  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_7AE5F777CC93  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 5,307,100,000 United States dollar", as of 2018-12-31 (until 2019-12-31). Claim clm_8C3635AEC49A, https://asof.is/claim/clm_8C3635AEC49A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947819000082/0000059478-19-000082-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-19  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947819000082/0000059478-19-000082-index.htm (primary, SEC EDGAR 10-K FY2018, published 2019-02-19)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 5,281,800,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_8C3635AEC49A](/claim/clm_8C3635AEC49A.md) | [clm_1D6D085414BC](/claim/clm_1D6D085414BC.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.